|
|
||||||||
RAPID COMMUNICATION |
Immunology Group, Paterson Institute for Cancer Research (PICR), Christie Hospital NHS Trust, Manchester, United Kingdom
Key Words. Embryonic stem cells • CMV • Transgene expression • Promoter • EGFP
Chris Ward, Ph.D. Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 4BX, United Kingdom. Telephone: 44-161-446-3157; Fax: 44-161-446-3109; e-mail: wardcm{at}hotmail.com
It has been reported recently that the cytomegalovirus (CMV) immediate-early promoter is transcriptionally inactive in undifferentiated mouse embryonic stem (ES) cells. This result is surprising, since the CMV promoter is used to express transgenes in a variety of cell lines. We studied the expression of a human CMV-driven enhanced green fluorescent protein (EGFP) reporter gene (pEGFP-N1) in five undifferentiated mouse ES cell lines (BL/6III, D3, E14TG2a, MESC20, and 129) and found EGFP expression in all of these cell lines. Under optimal conditions, between 50%-80% transfection efficiencies could be achieved, and EGFP expression levels were maintained for at least 72 hours. Therefore, the human CMV promoter remains a useful system for transgene expression in undifferentiated ES cells.
This article has been cited by other articles:
![]() |
D. Filipponi, R. M. Hobbs, S. Ottolenghi, P. Rossi, E. A. Jannini, P. P. Pandolfi, and S. Dolci Repression of kit Expression by Plzf in Germ Cells Mol. Cell. Biol., October 1, 2007; 27(19): 6770 - 6781. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lakshmipathy, B. Pelacho, K. Sudo, J. L. Linehan, E. Coucouvanis, D. S. Kaufman, and C. M. Verfaillie Efficient Transfection of Embryonic and Adult Stem Cells Stem Cells, July 1, 2004; 22(4): 531 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ward, K. Barrow, A. M. Woods, and P. L. Stern The 5T4 oncofoetal antigen is an early differentiation marker of mouse ES cells and its absence is a useful means to assess pluripotency J. Cell Sci., November 15, 2003; 116(22): 4533 - 4542. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Bartsevich, J. C. Miller, C. C. Case, and C. O. Pabo Engineered Zinc Finger Proteins for Controlling Stem Cell Fate Stem Cells, November 1, 2003; 21(6): 632 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zeng, J. Chen, J. F. Sanchez, M. Coggiano, O. Dillon-Carter, J. Petersen, and W. J. Freed Stable Expression of hrGFP by Mouse Embryonic Stem Cells: Promoter Activity in the Undifferentiated State and During Dopaminergic Neural Differentiation Stem Cells, November 1, 2003; 21(6): 647 - 653. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
